These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2071977)

  • 1. Treatment of intermittent claudication: two different mechanisms.
    Linhart J; Vanĕk I
    Int Angiol; 1991; 10(1):6-9. PubMed ID: 2071977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on changes in intermittent claudication after the administration of creatine phosphate.
    Favilli S; Iacopetti L; Fradella GA; Righi D; Nuzzaci G
    Pharmatherapeutica; 1982; 3(4):221-6. PubMed ID: 7146037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Walking distance and arterial flow during long term treatment of intermittent claudication with d-a-tocopherol.
    Haeger K
    Vasa; 1973; 2(3):280-7. PubMed ID: 4745137
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin and muscle flow during exercise in intermittent claudication.
    Koppelmann J
    Scand J Clin Lab Invest Suppl; 1973; 128():93-6. PubMed ID: 4764606
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional assessment at the buttock level of the effect of aortobifemoral bypass surgery.
    Jaquinandi V; Picquet J; Saumet JL; Benharash P; Leftheriotis G; Abraham P
    Ann Surg; 2008 May; 247(5):869-76. PubMed ID: 18438126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of beneficial action of daily walking training of patients with intermittent claudication.
    Schoop W
    Scand J Clin Lab Invest Suppl; 1973; 128():197-9. PubMed ID: 4764581
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of hypercholestrolemia on calf muscle hemoglobin oxygen saturation in patients with intermittent claudication.
    Afaq A; Montgomery PS; Scott KJ; Blevins SM; Whitsett TL; Gardner AW
    Angiology; 2008; 59(5):534-41. PubMed ID: 18388089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
    Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blood flow in calf muscles in normal man and in patients with obliterative arterial disease studied during walking by the Xe-133 clearance method.
    García del Río H
    Scand J Clin Lab Invest Suppl; 1967; 99():130-2. PubMed ID: 6056907
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood pressure in patients with intermittent claudication increases continuously during walking.
    Bakke EF; Hisdal J; Jørgensen JJ; Kroese A; Stranden E
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):20-5. PubMed ID: 16934498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of intermittent claudication by physical retraining of the non-hospitalised patient. Evaluation of effectiveness in a group of 40 patients (author's transl)].
    Dereume JP; Azama M; Barroy Y; Rondeux C; Goldstein M
    J Mal Vasc; 1980; 5(3):191-2. PubMed ID: 7462851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
    Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC; Moher D; Barber GG
    CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of enalapril on leg muscle blood flow in patients with claudication.
    Sonecha TN; Nicolaides AN; Kyprianou P; Zukowski A; Papadakis K; Vasdekis S; Salmasi AM
    Int Angiol; 1990; 9(1):22-4. PubMed ID: 2212796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of supervised treadmill walking training on calf muscle capillarization in patients with intermittent claudication.
    Wang J; Zhou S; Bronks R; Graham J; Myers S
    Angiology; 2009; 60(1):36-41. PubMed ID: 18505746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plethysmographic measurements of calf blood flow, and Xe-133 clearance from the calf muscle in patients with intermittent claudication.
    Hlavová A; Linhart J; Prerovský I; Oppelt A; Vavrejn B
    Cor Vasa; 1968; 10(2):99-109. PubMed ID: 5706099
    [No Abstract]   [Full Text] [Related]  

  • 19. Xenon-133 clearance studies during walking; effect on muscle and skin blood flow; routine application with comment on branch thrombosis below the knee.
    Larsen OA
    Scand J Clin Lab Invest Suppl; 1973; 128():89-92. PubMed ID: 4587558
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of exogenous phosphocreatine on maximal walking distance, blood rheology, platelet aggregation, and fibrinolysis in patients with intermittent claudication.
    Panchenko E; Dobrovolsky A; Rogoza A; Sorokin E; Ageeva N; Markova L; Titaeva E; Anuchin V; Karpov Y; Saks V
    Int Angiol; 1994 Mar; 13(1):59-64. PubMed ID: 8077800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.